z-logo
open-access-imgOpen Access
Neue Virostatika zur Behandlung von Hepatitis C
Author(s) -
Francesco Negro
Publication year - 2014
Publication title -
swiss medical forum ‒ schweizerisches medizin-forum
Language(s) - German
Resource type - Journals
eISSN - 1424-4020
pISSN - 1424-3784
DOI - 10.4414/smf.2014.01992
Subject(s) - sofosbuvir , simeprevir , virology , medicine , hepatitis c virus , ribavirin , virus
Die Zulassung zweier neuer Virostatika mit direkter Wirkung gegen das Hepatitis-C-Virus (HCV) wird fur 2014 erwartet: Sofosbuvir und Simeprevir.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom